Product Description
Product Name: Nintedanib Soft Gelatin Capsule
Strength: 150 mg
Form: Soft Gelatin Capsule
Category: Antifibrotic / Tyrosine Kinase Inhibitor
Indication: Idiopathic Pulmonary Fibrosis (IPF), Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD), and Other Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
Nintedanib 150 mg is a targeted antifibrotic therapy classified as a multi-tyrosine kinase inhibitor, used to slow disease progression in patients with fibrotic lung diseases. It is approved for the treatment of:
